Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1026.5
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 10-Feb-2026
NAV [Rs.]
: 22.7754
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.18 | -2.29 | -0.66 | 3.84 | 2.97 | 22.22 | - | 10.45 |
| Category Avg | 2.67 | 0.83 | 5.63 | 14.68 | 21.71 | 19.94 | 14.4 | 16.32 |
| Category Best | 8.78 | 9.37 | 69.15 | 118.02 | 160.63 | 53.59 | 35.66 | 199.64 |
| Category Worst | -89.9 | -89.57 | -83.17 | -78.42 | -15.22 | 6.05 | 5.12 | -22.88 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.29 | 1344676 | 214.51 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.69 | 161362 | 97.64 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 9.39 | 714490 | 94.59 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.36 | 773871 | 94.26 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.58 | 307849 | 66.27 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.22 | 132828 | 52.61 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 4.73 | 493401 | 47.61 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.26 | 355190 | 42.89 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 4.19 | 74302 | 42.18 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.83 | 191240 | 38.55 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.30 | 906088 | 33.23 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.03 | 143641 | 30.50 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.79 | 317779 | 28.13 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.58 | 176502 | 25.95 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.93 | 103837 | 19.41 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.85 | 101069 | 18.66 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.81 | 6629 | 18.27 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.48 | 53497 | 14.88 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.44 | 104894 | 14.49 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.21 | 785778 | 12.15 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
